You searched for "Hydroxychloroquine"

24 results found

Hydroxychloroquine toxicity

Being the subject of litigation is stressful and upsetting. Having to look back over your previous decisions and justify the care you delivered in good faith can be difficult. Sadly, we all live with the Sword of Damocles above us...

Screening for hydroxychloroquine retinopathy

The American Academy of Ophthalmology has updated the recommendations for screening for hydroxychloroquine retinopathy based on new scientific evidence that toxicity is not rare when hydroxychloroquine is used long-term, and that risk is dependent on the daily dose by weight....

Visual fields and OCT in hydroxychloroquine retinopathy

It has been recommended that patients on hydroxychloroquine be monitored regularly for retinopathy. However, there has not been an agreement as to the best screening test for hydroxychloroquine toxicity, which may include visual fields (VF), fundus autofluorescence, spectral domain optical...

Retinal changes prior to hydroxychloroquine toxicity

In this retrospective longitudinal study, the authors examined changes in retinal layer thickness in patients taking hydroxychloroquine without evidence of retinopathy. Patients were drawn from a hydroxychloroquine screening clinic and required at least two OCT scans, at least one year...

Heidelberg Engineering: An Objective Method of Diagnosing Hydroxychloroquine Maculopathy

@6:30 - 7:30pm (GMT) Hydroxychloroquine maculopathy is an irreversible cause of vision loss. This webinar aims to highlight how can macular changes be used to detect maculopathy at an early stage and prevent it from causing visual impairment. The webinar will be delivered by Mr Hani Hasan, MBBS, ChM, FRCOphth, Consultant Ophthalmic Surgeon, North West Anglia NHS Foundation Trust. There is 1 CET point approved for optometrists and dispensing opticians.

Imaging 2023

To skip directly to features, click the links below: Welcome from the editors - by Rosalyn Painter, Richard Bell Registration of imagers on a voluntary register - by Rosalyn Painter Slit-lamp imaging: more than a photo - by Dorren Agyeman,...

Learning from litigation: ocular drug toxicity

Being the subject of litigation is stressful and upsetting. Having to look back over your previous decisions and justify the care you delivered in good faith can be difficult. Sadly, we all live with the sword of Damocles above us...

Pathway innovations to address cataract services post-COVID-19

Background The demand for cataract services prior to the COVID-19 pandemic was already recognised to be high and growing - in the face of an ageing population and reduced surgical thresholds. When added to the growth in demand for ophthalmic...

The extended role of the specialist ophthalmic photographer

The prevalence of certain retinal conditions such as diabetic retinopathy and age-related macular degeneration (ARMD) is projected to grow substantially over the next decades. Estimates for the projected growth in burden on eye services for diabetic retinopathy and neovascular ARMD...

Paraproteinaemia: a patient with atypical corneal findings

A Bence Jones protein is a monoclonal globulin protein or immunoglobulin light chain found in the urine, with a molecular weight of 22-24 kDa [1]. Detection of Bence Jones protein may be suggestive of multiple myeloma or Waldenström’s macroglobulinemia. Multiple...

The results of the last survey Jun22

Thank you once more for your time in answering the latest survey. The first question relates to the number of staff required for a routine cataract list. There was a big variance in practice. Some of us are luckier than...

100% Ophthalmology Programme Insights

We spoke to some of the Eye News family about their upcoming presentations at 100% Opthalmology, 24–26 February 2024, ExCeL London, UK.
  • 1 (current)
  • 2